Plasma and cerebrospinal fluid neurofilament light concentrations reflect neuronal damage in systemic lupus Erythematosus

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1471-2377
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Plasma and cerebrospinal fluid neurofilament light concentrations reflect neuronal damage in systemic lupus Erythematosus ; volume:22 ; number:1 ; day:9 ; month:12 ; year:2022 ; pages:1-12 ; date:12.2022
BMC neurology ; 22, Heft 1 (9.12.2022), 1-12, 12.2022

Creator
Zervides, Kristoffer A.
Janelidze, Shorena
Nystedt, Jessika
Gullstrand, Birgitta
Nilsson, Petra
Sundgren, Pia C.
Bengtsson, Anders A.
Hansson, Oskar
Jönsen, Andreas
Contributor
SpringerLink (Online service)

DOI
10.1186/s12883-022-02998-3
URN
urn:nbn:de:101:1-2023021909091593208083
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:53 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Zervides, Kristoffer A.
  • Janelidze, Shorena
  • Nystedt, Jessika
  • Gullstrand, Birgitta
  • Nilsson, Petra
  • Sundgren, Pia C.
  • Bengtsson, Anders A.
  • Hansson, Oskar
  • Jönsen, Andreas
  • SpringerLink (Online service)

Other Objects (12)

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease

Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease

Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease

Changes in cerebrospinal fluid and blood plasma levels of IGF-II and its binding proteins in Alzheimer’s disease: an observational study

Changes in cerebrospinal fluid and blood plasma levels of IGF-II and its binding proteins in Alzheimer’s disease: an observational study

Effects of certain pre-analytical factors on the performance of plasma phospho-tau217

Effects of certain pre-analytical factors on the performance of plasma phospho-tau217

Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer’s disease

Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer’s disease

Characterization of degradation and heterozygote balance by simulation of the forensic DNA analysis process

Characterization of degradation and heterozygote balance by simulation of the forensic DNA analysis process

Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders

Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders

Cerebrospinal fluid concentrations of inflammatory markers in Parkinson’s disease and atypical parkinsonian disorders

Cerebrospinal fluid concentrations of inflammatory markers in Parkinson’s disease and atypical parkinsonian disorders

Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease

Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease

External validation of a 3-step falls prediction model in mild Parkinson’s disease

External validation of a 3-step falls prediction model in mild Parkinson’s disease

Towards a unified protocol for handling of CSF before β-amyloid measurements

Towards a unified protocol for handling of CSF before β-amyloid measurements

Novel insights regarding the measurement properties of the SCOPA-AUT

Novel insights regarding the measurement properties of the SCOPA-AUT

Related objects